(NYSE: ANRO) Alto Neuroscience's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.9%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.76%.
Alto Neuroscience's earnings in 2026 is -$95,181,000.On average, 13 Wall Street analysts forecast ANRO's earnings for 2026 to be -$113,962,294, with the lowest ANRO earnings forecast at -$130,896,997, and the highest ANRO earnings forecast at -$100,236,439. On average, 13 Wall Street analysts forecast ANRO's earnings for 2027 to be -$122,963,117, with the lowest ANRO earnings forecast at -$161,164,471, and the highest ANRO earnings forecast at -$80,020,687.
In 2028, ANRO is forecast to generate -$122,261,181 in earnings, with the lowest earnings forecast at -$171,777,741 and the highest earnings forecast at -$92,234,371.